Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study
Howard S. Höchster(Rutgers, The State University of New Jersey), Eric Hedrick(Florida Hospital Cancer Institute), Muhammad Wasif Saif(Wayne State University), John D. Hainsworth(Sarah Cannon), Lee S. Schwartzberg(Renown Health), Louis Fehrenbacher(Kaiser Permanente Vallejo Medical Center), Yousif Abubakr(Florida Hospital Cancer Institute), Lowell L. Hart(Florida Cancer Specialists & Research Institute), Allen Lee Cohn(Rocky Mountain Cancer Centers), Lucas Wong(Florida Hospital Cancer Institute), Ramesh K. Ramanathan(Ironwood Pharmaceuticals (United States)), Barrett H. Childs(Florida Hospital Cancer Institute)
Cited by 623
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k